University of Kansas;The Scripps Research Institute
发明人:
Jeffrey Aube,Laura Bohn,Thomas Edward Prisinzano,Frank John Schoenen,Kevin J. Frankowski
申请号：
US15156887
公开号：
US09540375B2
申请日:
2016.05.17
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention is a selective kappa opioid receptor effector, or a pharmaceutically acceptable salt thereof, useful for treating ethanol use disorder withdrawal, anxiety and/or depression, schizophrenia, mania or post-traumatic stress disorder.
